Visceral Pain Market Overview, Growth and Trend Analysis, 2014 to 2024
The global visceral pain market size was estimated at USD 9.51 billion in 2016 and is expected to witness substantial growth on account of its increasing prevalence.
(firmenpresse) - The global visceral pain market is expected to reach USD 14.22 billion by 2024, driven by the increasing geriatric population globally. Increasing prevalence of visceral pain and rising awareness regarding the same is projected to drive market growth over the forecast period.
In 2016, North America held the majority of share in global visceral pain market owing to the increasing healthcare expenditure. Additionally, the high prevalence of Crohn
Asia Pacific is expected to be the fastest growing region with the CAGR of 6.2%. The increase in the healthcare infrastructure and presence of a large pool of patients is projected to drive the demand for the visceral pain industry during the forecast period.
Analgesic segment dominated the market for the visceral pain with the market share of 60.4%. The major share of the analgesic segment is attributed to the increasing penetration of generic drug. Furthermore, rising healthcare expenditure and an increasing use of opioids for the chronic pain are the key factors attributing to its share.
In 2016, Crohn
Key market players include Pfizer, Johnson & Johnson, Abbvie, Takeda, Allergan, and AstraZeneca. These companies are focusing on R&D for visceral pain therapeutics. These companies are likely to cater their products to patients affected by visceral pain. The growth of the geriatric population is expected to help in augmenting the profits of these companies over the next few years.
Growing focus on research and development by pharmaceutical companies and government initiatives are expected to boost the visceral pain industry during the forecast period. The market is projected to witness significant gain during the forecast period owing to increasing collaboration within pharmaceutical companies. Also, factors such as increasing awareness among people regarding visceral pain are further anticipated to propel the market growth.
Hexa Research has segmented the global visceral pain market on the basis of therapeutics, indications and region:
Segmentation by therapeutics, 2014 - 2024 (USD Million)
Segmentation by indications, 2014 - 2024 (USD Million)
Segmentation by region, 2014 - 2024 (USD Million)
Key players analyzed:
& Johnson
Themen in dieser Pressemitteilung:
visceral-pain-market
visceral-pain-industry
clinical-diagnostics
visceral-pain-market-analysis
visceral-pain
healthcare
Unternehmensinformation / Kurzprofil:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales(at)hexaresearch.com
Website - https://www.hexaresearch.com/
Datum: 13.07.2018 - 06:42 Uhr
Sprache: Deutsch
News-ID 1538513
Anzahl Zeichen: 3595
contact information:
Contact person: Ryan Shaw
Town:
Felton
Phone: +1-800-489-3075
Kategorie:
Healthcare
Typ of Press Release: Finanzinformation
type of sending: Veröffentlichung
Date of sending: 13.07.2018
Anmerkungen:
Diese Pressemitteilung wurde bisher 618 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Visceral Pain Market Overview, Growth and Trend Analysis, 2014 to 2024
"
steht unter der journalistisch-redaktionellen Verantwortung von
Hexa Research (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
